Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.036
General Information
Version
9.0
Revision date
2026-04-20
Product name
A424
1.2.1 Relevant identified uses
Industrial/Professional use spec Industrial
Manufacturer Name
C/Plató
Emergency telephone
+34 93 849 6188
Icons in SDS
Company Information
company name
DERYPOL, S.A HQ
e-mail address of the competent person responsible for the Safety Data Sheet
regulatory@derypol.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P337+P313 - If eye irritation persists: Get medical advice/attention.
Supplemental label elements
EUH208 - Contains 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one. May produce an allergic reaction.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available